| iloperidone / Generic mfg. |
| Completed | 4 | 501 | US | iloperidone, Fanaptâ„¢ | Novartis | Schizophrenia | 01/12 | 01/12 | | |
NCT01929889: Assessing the Effects of Fanapt® on Social Cognition in Schizophrenia |
|
|
| Terminated | 4 | 19 | US | Iloperidone, Fanapt | Northwestern University, Novartis Pharmaceuticals | Schizophrenia, Schizoaffective Disorder | 02/14 | 10/14 | | |
NCT01920802: Assessment and Comparison of Metabolic Changes in Non-psychotic Adults Taking Iloperidone or Olanzapine or Placebo |
|
|
| Completed | 4 | 31 | US | olanzapine, Zyprexa, iloperidone, Fanapt, Placebo | New York State Psychiatric Institute, Novartis Pharmaceuticals | Healthy | 08/14 | 09/14 | | |
NCT01464229: Iloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and Irritability |
|
|
| Completed | 4 | 20 | US | Iloperidone, Placebo | Maurizio Fava, MD, Novartis Pharmaceuticals | Major Depressive Disorder | 12/14 | 12/14 | | |
NCT02413918: Iloperidone in Mixed States of Bipolar Disorder |
|
|
| Completed | 4 | 41 | US | iloperidone, Fanapt | The University of Texas Health Science Center at San Antonio, Novartis Pharmaceuticals, Vanda Pharmaceuticals | Bipolar Disorder | 04/15 | 04/15 | | |
NCT05648591: Safety and Tolerability of Open-Labeled Iloperidone in Adolescents |
|
|
| Recruiting | 4 | 100 | US | Iloperidone, VYV-683, FANAPT | Vanda Pharmaceuticals | Schizophrenia, Bipolar I Disorder | 09/24 | 09/24 | | |
